P. Parini

1.0k total citations
14 papers, 816 citations indexed

About

P. Parini is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, P. Parini has authored 14 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in P. Parini's work include Cancer, Lipids, and Metabolism (3 papers), Cholesterol and Lipid Metabolism (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). P. Parini is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Cholesterol and Lipid Metabolism (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). P. Parini collaborates with scholars based in Sweden, Italy and United States. P. Parini's co-authors include Bo Angelin, Bihu Gao, Renhai Cao, Barbara Cannon, Ebba Bråkenhielm, Yihai Cao, Olle Vidal, Claes Ohlsson, Marie K. Lindberg and Margaret Warner and has published in prestigious journals such as PLoS ONE, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

P. Parini

13 papers receiving 799 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Parini Sweden 9 315 236 202 155 151 14 816
Agata Kubaszek Finland 10 257 0.8× 201 0.9× 201 1.0× 153 1.0× 191 1.3× 12 712
Monique Verdier France 13 552 1.8× 324 1.4× 255 1.3× 66 0.4× 128 0.8× 17 1.0k
Marco R. Schroeter Germany 14 158 0.5× 181 0.8× 226 1.1× 78 0.5× 94 0.6× 24 752
Ilham Kharroubi Belgium 8 368 1.2× 237 1.0× 271 1.3× 208 1.3× 178 1.2× 8 964
Anette A. Pedersen Denmark 6 389 1.2× 262 1.1× 139 0.7× 84 0.5× 55 0.4× 8 663
Marjorie Poggi France 15 483 1.5× 323 1.4× 368 1.8× 99 0.6× 104 0.7× 29 1.2k
Esther Dos Santos France 18 352 1.1× 185 0.8× 200 1.0× 88 0.6× 70 0.5× 33 1.1k
David Vallois France 10 153 0.5× 152 0.6× 243 1.2× 161 1.0× 139 0.9× 14 727
Mirjana Šumarac-Dumanović Serbia 14 235 0.7× 168 0.7× 440 2.2× 60 0.4× 123 0.8× 45 1.0k
Michelle Kirby United States 12 471 1.5× 335 1.4× 243 1.2× 78 0.5× 293 1.9× 16 933

Countries citing papers authored by P. Parini

Since Specialization
Citations

This map shows the geographic impact of P. Parini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Parini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Parini more than expected).

Fields of papers citing papers by P. Parini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Parini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Parini. The network helps show where P. Parini may publish in the future.

Co-authorship network of co-authors of P. Parini

This figure shows the co-authorship network connecting the top 25 collaborators of P. Parini. A scholar is included among the top collaborators of P. Parini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Parini. P. Parini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Parini, P.. (2025). The use of different types of networks, alone and in combination, for drug target identification. British Journal of Pharmacology. 183(8). 1653–1662.
2.
Ossoli, Alice, Massimiliano Ruscica, Claudio Rabacchi, et al.. (2022). HDL‐mediated reduction of cholesterol content inhibits the proliferation of prostate cancer cells induced by LDL: Role of ABCA1 and proteasome inhibition. BioFactors. 48(3). 707–717. 7 indexed citations
3.
Ahmed, Osama, Chiara Pirazzini, Emiliano Marasco, et al.. (2021). Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19. Atherosclerosis. 331. e143–e144. 1 indexed citations
4.
Gnocchi, Davide, Knut R. Steffensen, G. Bruscalupi, & P. Parini. (2016). Emerging role of thyroid hormone metabolites. Acta Physiologica. 217(3). 184–216. 26 indexed citations
5.
Ellis, Ewa, P. Parini, Carl Jorns, et al.. (2013). Mice with Chimeric Livers Are an Improved Model for Human Lipoprotein Metabolism. PLoS ONE. 8(11). e78550–e78550. 41 indexed citations
6.
Albåge, Anders, Gösta Eggertsen, & P. Parini. (2011). Late Cardiac Tamponade by Chylous Pericardial Effusion after Coronary Artery Bypass Surgery: Case Report. The Heart Surgery Forum. 14(3). 195–195. 1 indexed citations
7.
Pramfalk, Camilla, Bo Angelin, Mats Eriksson, & P. Parini. (2008). CHOLESTEROL REGULATES ACAT2 GENE EXPRESSION AND ENZYME ACTIVITY IN HUMAN HEPATOMA CELLS. Atherosclerosis Supplements. 9(1). 33–33. 1 indexed citations
8.
Zhou, Xinghua, Anna-Karin L. Robertson, Mats Rudling, P. Parini, & Göran K. Hansson. (2005). Lesion Development and Response to Immunization Reveal a Complex Role for CD4 in Atherosclerosis. Circulation Research. 96(4). 427–434. 112 indexed citations
9.
Bråkenhielm, Ebba, Renhai Cao, Bihu Gao, et al.. (2004). Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice. Circulation Research. 94(12). 1579–1588. 244 indexed citations
10.
Steffensen, Knut R., Gertrud U. Schuster, P. Parini, et al.. (2002). Different regulation of the LXRα promoter activity by isoforms of CCAAT/enhancer-binding proteins. Biochemical and Biophysical Research Communications. 293(5). 1333–1340. 26 indexed citations
11.
Ohlsson, Claes, P. Parini, Olle Vidal, et al.. (2000). Obesity and Disturbed Lipoprotein Profile in Estrogen Receptor-α-Deficient Male Mice. Biochemical and Biophysical Research Communications. 278(3). 640–645. 272 indexed citations
12.
Parini, P.. (1995). Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells. Endocrinology. 136(9). 3767–3773. 17 indexed citations
13.
Festi, Davide, G. Mazzella, P. Parini, et al.. (1993). Treatment of hepatic encephalopathy with non-absorbable antibiotics.. PubMed. 24(9 Suppl 2). 14–6. 11 indexed citations
14.
Festi, Davide, G. Mazzella, S. Sottili, et al.. (1993). Rifaximin in the treatment of chronic hepatic encephalopathy; results of a multicenter study of efficacy and safety. Current Therapeutic Research. 54(5). 598–609. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agata Kubaszek Breakdown of academic impact, for papers by Monique Verdier Breakdown of academic impact, for papers by Marco R. Schroeter Breakdown of academic impact, for papers by Ilham Kharroubi Breakdown of academic impact, for papers by Anette A. Pedersen Breakdown of academic impact, for papers by Marjorie Poggi Breakdown of academic impact, for papers by Esther Dos Santos Breakdown of academic impact, for papers by David Vallois Breakdown of academic impact, for papers by Mirjana Šumarac-Dumanović Breakdown of academic impact, for papers by Michelle Kirby
Rankless by CCL
2026